Go

Breaking News on Pharmaceutical Technology

All feeds

News headlines > Materials & Formulation

Text size Print Email this page

Cosmo gets to the bottom of IBD

By Katrina Megget, 19-Jun-2007

Related topics: Materials & Formulation, Drug delivery systems, Ingredients, excipients and raw materials

Cosmo Pharmaceuticals is cementing its place in the inflammatory bowel disease (IBD) drug market with eight new drugs in various stages of reformulation using the company's cutting-edge MMX technology, the company announced recently.

Related Products, Brochures, Web links

Product presentations